Elsayed Balbaa: Baseline Anemia Predicts Adverse 12-Month Outcomes After Elective PCI for Stable CAD
Elsayed Balbaa, Student of Alexandria University, shared a post on LinkedIn:
“A new Publication!
We found that in men undergoing first-time elective PCI for stable CAD, baseline anemia was associated with higher 12-month risks of AKI, major bleeding, need for transfusion, hospitalization, and death, especially with recent (≤ 1 year) bleeding or transfusion history.”
Mohamed R. Murad, Bachelor of Medicine, Bachelor of Surgery – MBBS at Al-Azhar University, shared a post on LinkedIn:
“Pleased to share our recent publication:
‘Prognostic Impact of Baseline Anemia on Outcomes After Elective PCI in Men: A US Retrospective Cohort Study.’
In this study, we examined the prognostic impact of baseline anemia on outcomes after elective PCI in men with stable coronary artery disease.
Our analysis incorporated survival analysis, Kaplan-Meier curves, log-rank testing, univariable and multivariable Cox proportional hazards regression, propensity score matching, falsification (negative-control) endpoint analysis, E-value sensitivity analysis, and multiple-testing adjustment using Benjamini-Hochberg and Bonferroni methods.
I’m truly happy to be part of this great work with such outstanding leaders, collaborators, and team members.
I’m deeply grateful for the guidance, dedication, and shared effort of all co-authors who contributed to this study.
Proud to contribute to research that advances clinical understanding and supports better patient care.”
Title: Catheterization and Cardiovascular Interventions
Authors: Abdalhakim Shubietah, Mohamed S. Elgendy, Mohamed Saad Rakab, Ahmed Ahmed, Batoul Abusalah, Mohamed R. Murad, Belal Mohamed Hamed, Hamza A. Abdul-Hafez, Ahmed Emara, Qutaiba Qafisheh, Elsayed Balbaa, Ameer Awashra, Ahmed Mansour, Ahmed Elbataa, Abdalrahman Assaassa, Mohammed Mhanna
Read the Article on Catheterization and Cardiovascular Interventions
Stay updated on all scientific advances with Hemostasis Today.
-
May 22, 2026, 16:30Buse Bor: New Publication on Therapeutic Interventions for Women with Obstetric APS
-
May 22, 2026, 16:29Danny Hsu: The Reversal Dilemma – Rethinking our approach to DOAC-associated ICH
-
May 22, 2026, 16:28Bartosz Hudzik: High Bleeding Risk Does Not Always Mean Bleeding-Risk Predominance
-
May 22, 2026, 16:26Sandeep De: Omicron COVID Infections Linked to Coronary Thrombosis without Detectable Plaque
-
May 22, 2026, 16:25Edward Lee Carter: What Is Changing in Antiplatelet Deprescribing and Why It Matters
-
May 22, 2026, 15:02Robert Brodsky: Can You Stop Thrombosis and Treat CAPS Without Anticoagulation?
-
May 22, 2026, 14:50Eric Topol: New Nature Editorial on the Limits and Promise of AI Scientists
-
May 22, 2026, 14:40Harry Spoelstra: Omicron COVID-19 and Coronary Thrombosis Without Atherosclerosis
-
May 22, 2026, 14:21Clinical Challenges in Thrombosis III – Thrombosis Canada